Omeros Price to Free Cash Flow Ratio 2012-2026 | OMER
Historical price to free cash flow ratio values for Omeros (OMER) since 2012.
| Omeros Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-18 | 17.87 | 0.00 | |
| 2026-06-30 | 9.51 | $-0.96 | 0.00 |
| 2026-03-31 | 10.56 | $-1.37 | 0.00 |
| 2025-12-31 | 17.18 | $-1.83 | 0.00 |
| 2025-09-30 | 4.10 | $-1.64 | 0.00 |
| 2025-06-30 | 3.00 | $-2.03 | 0.00 |
| 2025-03-31 | 8.22 | $-2.47 | 0.00 |
| 2024-12-31 | 9.88 | $-2.56 | 0.00 |
| 2024-09-30 | 3.97 | $-2.62 | 0.00 |
| 2024-06-30 | 4.06 | $-2.59 | 0.00 |
| 2024-03-31 | 3.45 | $-2.31 | 0.00 |
| 2023-12-31 | 3.27 | $1.18 | 2.76 |
| 2023-09-30 | 2.92 | $1.33 | 2.19 |
| 2023-06-30 | 5.44 | $1.43 | 3.80 |
| 2023-03-31 | 4.65 | $1.64 | 2.84 |
| 2022-12-31 | 2.26 | $-1.38 | 0.00 |
| 2022-09-30 | 3.15 | $-1.27 | 0.00 |
| 2022-06-30 | 2.75 | $-1.23 | 0.00 |
| 2022-03-31 | 6.01 | $-1.36 | 0.00 |
| 2021-12-31 | 6.43 | $-1.76 | 0.00 |
| 2021-09-30 | 13.79 | $-1.82 | 0.00 |
| 2021-06-30 | 14.84 | $-1.98 | 0.00 |
| 2021-03-31 | 17.80 | $-2.24 | 0.00 |
| 2020-12-31 | 14.29 | $-1.76 | 0.00 |
| 2020-09-30 | 10.11 | $-1.87 | 0.00 |
| 2020-06-30 | 14.72 | $-1.47 | 0.00 |
| 2020-03-31 | 13.37 | $-1.12 | 0.00 |
| 2019-12-31 | 14.09 | $-1.22 | 0.00 |
| 2019-09-30 | 16.33 | $-1.27 | 0.00 |
| 2019-06-30 | 15.69 | $-1.87 | 0.00 |
| 2019-03-31 | 17.37 | $-2.18 | 0.00 |
| 2018-12-31 | 11.14 | $-2.15 | 0.00 |
| 2018-09-30 | 24.41 | $-1.74 | 0.00 |
| 2018-06-30 | 18.14 | $-1.20 | 0.00 |
| 2018-03-31 | 11.17 | $-0.75 | 0.00 |
| 2017-12-31 | 19.43 | $-0.80 | 0.00 |
| 2017-09-30 | 21.62 | $-0.99 | 0.00 |
| 2017-06-30 | 19.91 | $-1.01 | 0.00 |
| 2017-03-31 | 15.12 | $-1.13 | 0.00 |
| 2016-12-31 | 9.92 | $-1.28 | 0.00 |
| 2016-09-30 | 11.16 | $-1.45 | 0.00 |
| 2016-06-30 | 10.52 | $-1.59 | 0.00 |
| 2016-03-31 | 15.34 | $-1.70 | 0.00 |
| 2015-12-31 | 15.73 | $-1.74 | 0.00 |
| 2015-09-30 | 10.96 | $-1.79 | 0.00 |
| 2015-06-30 | 17.99 | $-1.87 | 0.00 |
| 2015-03-31 | 22.03 | $-1.87 | 0.00 |
| 2014-12-31 | 24.78 | $-1.75 | 0.00 |
| 2014-09-30 | 12.72 | $-1.30 | 0.00 |
| 2014-06-30 | 17.40 | $-1.17 | 0.00 |
| 2014-03-31 | 12.07 | $-1.06 | 0.00 |
| 2013-12-31 | 11.29 | $-1.05 | 0.00 |
| 2013-09-30 | 9.75 | $-1.60 | 0.00 |
| 2013-06-30 | 5.04 | $-1.47 | 0.00 |
| 2013-03-31 | 4.12 | $-1.56 | 0.00 |
| 2012-12-31 | 5.19 | $-1.46 | 0.00 |
| 2012-09-30 | 9.40 | $-1.19 | 0.00 |
| 2012-06-30 | 10.00 | $-1.16 | 0.00 |
| 2012-03-31 | 9.93 | $-1.07 | 0.00 |
| 2011-12-31 | 3.95 | $-1.21 | 0.00 |
| 2011-09-30 | 4.05 | $-0.57 | 0.00 |
| 2011-06-30 | 4.12 | $-0.67 | 0.00 |
| 2011-03-31 | 8.00 | $-0.73 | 0.00 |
| 2010-12-31 | 8.24 | $-0.71 | 0.00 |
| 2010-09-30 | 7.29 | $-3.69 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.336B | $0.000B |
| Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.548B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |